Landos Biopharma CEO Gregory Oakes receives $1.8M in 2022
Landos Biopharma reports 2022 executive compensation
By ExecPay News
Published: April 19, 2023
Landos Biopharma reported fiscal year 2022 executive compensation information on April 19, 2023.
In 2022, five executives at Landos Biopharma received on average a compensation package of $679K, a 63% decrease compared to previous year.
Average pay of disclosed executives at Landos Biopharma
Gregory Oakes, Chief Executive Officer, received $1.8M in total. 54% of Oakes' compensation, or $957K, was in option awards. Oakes also received $150K in bonus, $325K in non-equity incentive plan, $321K in salary, as well as $11K in other compensation.
Tim M. Mayleben, Chief Executive Officer, received a compensation package of $566K, which decreased by 50% compared to previous year. 49% of the compensation package, or $275K, was in bonus.
Fabio Cataldi, Chief Medical Officer, earned $478K in 2022.
Patrick Truesdell, Vice President and Controller, received $325K in 2022.
Patricia Bitar, Chief Financial Officer, earned $262K in 2022, a 23% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on April 19, 2023.